Home/Filings/4/0001609351-19-000060
4//SEC Filing

SIGAL ELLIOT 4

Accession 0001609351-19-000060

CIK 0001609351other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:19 PM ET

Size

6.9 KB

Accession

0001609351-19-000060

Insider Transaction Report

Form 4
Period: 2019-05-30
SIGAL ELLIOT
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2019-05-301,5000 total
    Common Stock (1,500 underlying)
  • Exercise/Conversion

    Common Stock

    2019-05-30+1,50014,214 total
Footnotes (3)
  • [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
  • [F3]On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date. Vested shares are delivered to the reporting person on the vesting date.

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeother

Related Parties

1
  • filerCIK 0001202294

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:19 PM ET
Size
6.9 KB